<DOC>
	<DOC>NCT00689858</DOC>
	<brief_summary>TO assess the PK/PD effect of co-administerd Cilostazol with Ginkgo biloba or placebo, Phase I study in healthy Volunteers were designed</brief_summary>
	<brief_title>Study to Assess the Effect of Pharmacokinetics/Pharmacodynamics (PK/PD) Interaction After co-Administration of Cilostazol With Ginkgo Biloba or Placebo</brief_title>
	<detailed_description />
	<mesh_term>Cilostazol</mesh_term>
	<criteria>healthy male adult volunteer between 19 and 45 years of age and within 15% of ideal body weight by broca's formula. the subjects who doesn't have any congenital or chronic diseases and symptoms or signs of diseases after physical examinations.] the subject who has abnornal lab. ( In particular, AST or ALT &gt; 1.25 times of upper limit / Total bilirubin &gt; 1.5 times of upper limit/170,000 &lt; Platelet &lt; 360,000 / PT or aPTT or BT&gt; &gt;upper limit the subject who receive any metabolic enzyme inducing or inhibiting drugs like barbiturates or drink excess alcohol within 1 month prior to the study.</criteria>
	<gender>Male</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>June 2008</verification_date>
	<keyword>Healthy volunteers</keyword>
</DOC>